Skip to main content
Erschienen in: Journal of General Internal Medicine 4/2014

01.04.2014 | Multimorbidity Symposium

A Framework for Crafting Clinical Practice Guidelines that are Relevant to the Care and Management of People with Multimorbidity

verfasst von: Katrin Uhlig, MS, MD, Bruce Leff, MD, David Kent, MD, Cm, MSc, Sydney Dy, MD, MSc, Klara Brunnhuber, MD, Jako S. Burgers, MD, PhD, Sheldon Greenfield, MD, Gordon Guyatt, MD, MSc, Kevin High, MD, Rosanne Leipzig, MD, PhD, Cynthia Mulrow, MD, MSc, Kenneth Schmader, MD, Holger Schunemann, MD, MSc, PhD, Louise C. Walter, MD, James Woodcock, PhD, MSc, BA(Hons), Cynthia M. Boyd, MD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

ABSTRACT

Many patients of all ages have multiple conditions, yet clinicians often lack explicit guidance on how to approach clinical decision-making for such people. Most recommendations from clinical practice guidelines (CPGs) focus on the management of single diseases, and may be harmful or impractical for patients with multimorbidity. A major barrier to the development of guidance for people with multimorbidity stems from the fact that the evidence underlying CPGs derives from studies predominantly focused on the management of a single disease. In this paper, the investigators from the Improving Guidelines for Multimorbid Patients Study Group present consensus-based recommendations for guideline developers to make guidelines more useful for the care of people with multimorbidity. In an iterative process informed by review of key literature and experience, we drafted a list of issues and possible approaches for addressing important coexisting conditions in each step of the guideline development process, with a focus on considering relevant interactions between the conditions, their treatments and their outcomes. The recommended approaches address consideration of coexisting conditions at all major steps in CPG development, from nominating and scoping the topic, commissioning the work group, refining key questions, ranking importance of outcomes, conducting systematic reviews, assessing quality of evidence and applicability, summarizing benefits and harms, to formulating recommendations and grading their strength. The list of issues and recommendations was reviewed and refined iteratively by stakeholders. This framework acknowledges the challenges faced by CPG developers who must make complex judgments in the absence of high-quality or direct evidence. These recommendations require validation through implementation, evaluation and refinement.
Literatur
1.
Zurück zum Zitat Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.PubMedCrossRef Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.PubMedCrossRef
2.
Zurück zum Zitat Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the american geriatrics society: american geriatrics society expert panel on the care of older adults with multimorbidity. J Am Geriatr Soc. 2012;60(10):1957–68. Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the american geriatrics society: american geriatrics society expert panel on the care of older adults with multimorbidity. J Am Geriatr Soc. 2012;60(10):1957–68.
3.
Zurück zum Zitat Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–4.PubMedCrossRef Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–4.PubMedCrossRef
4.
Zurück zum Zitat Fabbri LM, Boyd C, Boschetto P, Rabe KF, Buist AS, Yawn B, et al. How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012;9(5):274–81.PubMedCrossRef Fabbri LM, Boyd C, Boschetto P, Rabe KF, Buist AS, Yawn B, et al. How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012;9(5):274–81.PubMedCrossRef
5.
Zurück zum Zitat Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24.PubMedCrossRef Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24.PubMedCrossRef
6.
Zurück zum Zitat Schoen C, Osborn R, Doty MM, Bishop M, Peugh J, Murukutla N. Toward higher-performance health systems: adults’ health care experiences in seven countries, 2007. Health Aff (Millwood). 2007;26(6):w717–34.CrossRef Schoen C, Osborn R, Doty MM, Bishop M, Peugh J, Murukutla N. Toward higher-performance health systems: adults’ health care experiences in seven countries, 2007. Health Aff (Millwood). 2007;26(6):w717–34.CrossRef
7.
Zurück zum Zitat Lugtenberg M, Burgers JS, Clancy C, Westert GP, Schneider EC. Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of evidence-based guidelines. PLoS ONE. 2011;6(10):e25987.PubMedCentralPubMedCrossRef Lugtenberg M, Burgers JS, Clancy C, Westert GP, Schneider EC. Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of evidence-based guidelines. PLoS ONE. 2011;6(10):e25987.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 Suppl Guidelines):S265–80.PubMed Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 Suppl Guidelines):S265–80.PubMed
9.
Zurück zum Zitat Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):7S–47S.PubMedCentralPubMedCrossRef Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):7S–47S.PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Department of Health and Human Services Strategic Framework on Multiple Chronic Conditions, 2010. Department of Health and Human Services Strategic Framework on Multiple Chronic Conditions, 2010.
12.
Zurück zum Zitat Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297(11):1233–40.PubMedCrossRef Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297(11):1233–40.PubMedCrossRef
13.
Zurück zum Zitat Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53(12):2480–6.PubMedCentralPubMedCrossRef Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53(12):2480–6.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Braithwaite RS, Fiellin D, Justice AC. The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines. Med Care. 2009;47(6):610–7.PubMedCentralPubMedCrossRef Braithwaite RS, Fiellin D, Justice AC. The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines. Med Care. 2009;47(6):610–7.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Braithwaite RS, Concato J, Chang CC, Roberts MS, Justice AC. A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med. 2007;167(21):2361–5.PubMedCentralPubMedCrossRef Braithwaite RS, Concato J, Chang CC, Roberts MS, Justice AC. A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med. 2007;167(21):2361–5.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289(18):2387–92.PubMedCrossRef Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289(18):2387–92.PubMedCrossRef
19.
Zurück zum Zitat Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians? BMJ. 2008;336(7651):995–8.PubMedCentralPubMedCrossRef Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians? BMJ. 2008;336(7651):995–8.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.PubMedCentralPubMedCrossRef Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006;174(5):605–14.PubMedCrossRef Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006;174(5):605–14.PubMedCrossRef
22.
Zurück zum Zitat Barton MB, Miller T, Wolff T, Petitti D, LeFevre M, Sawaya G, et al. How to read the new recommendation statement: methods update from the U.S. Preventive Services Task Force. Ann Intern Med. 2007;147(2):123–7.PubMedCrossRef Barton MB, Miller T, Wolff T, Petitti D, LeFevre M, Sawaya G, et al. How to read the new recommendation statement: methods update from the U.S. Preventive Services Task Force. Ann Intern Med. 2007;147(2):123–7.PubMedCrossRef
23.
Zurück zum Zitat Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med. 2009;150(3):199–205.PubMedCrossRef Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med. 2009;150(3):199–205.PubMedCrossRef
24.
Zurück zum Zitat Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al. AHRQ Series Paper 5: grading the strength of a body of evidence when comparing medical interventions—Agency for Healthcare Research and Quality and the Effective Health-Care Program. J Clin Epidemiol. 2010;63(5):513–23.PubMedCrossRef Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al. AHRQ Series Paper 5: grading the strength of a body of evidence when comparing medical interventions—Agency for Healthcare Research and Quality and the Effective Health-Care Program. J Clin Epidemiol. 2010;63(5):513–23.PubMedCrossRef
25.
Zurück zum Zitat Institute of Medicine. Clinical Practice Guidelines We Can Trust: The National Academies Press, 2011. Institute of Medicine. Clinical Practice Guidelines We Can Trust: The National Academies Press, 2011.
26.
Zurück zum Zitat National Institute for Clinical Excellence. Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. London: National Institute for Clinical Excellence; 2004. Updated 2005. National Institute for Clinical Excellence. Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. London: National Institute for Clinical Excellence; 2004. Updated 2005.
28.
Zurück zum Zitat Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40(11):1559–85.PubMedCrossRef Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40(11):1559–85.PubMedCrossRef
29.
Zurück zum Zitat KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(2 Suppl 2):S12–154. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(2 Suppl 2):S12–154.
30.
Zurück zum Zitat Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, et al. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med. 2010;152(11):738–41.PubMedCrossRef Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, et al. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med. 2010;152(11):738–41.PubMedCrossRef
31.
Zurück zum Zitat Uhlig K, Boyd C. Guidelines for the older adult with CKD. Am J Kidney Dis. 2011;58(2):162–5.PubMedCrossRef Uhlig K, Boyd C. Guidelines for the older adult with CKD. Am J Kidney Dis. 2011;58(2):162–5.PubMedCrossRef
32.
Zurück zum Zitat Parker MG, Atkins MB, Ucci AA, Levey AS. Rapidly progressive glomerulonephritis after immunotherapy for cancer. J Am Soc Nephrol. 1995;5(10):1740–4.PubMed Parker MG, Atkins MB, Ucci AA, Levey AS. Rapidly progressive glomerulonephritis after immunotherapy for cancer. J Am Soc Nephrol. 1995;5(10):1740–4.PubMed
33.
Zurück zum Zitat Giovannetti ER, Wolff JL, Xue QL, Weiss CO, Leff B, Boult C, et al. Difficulty assisting with health care tasks among caregivers of multimorbid older adults. J Gen Intern Med. 2012;27(1):37–44.PubMedCentralPubMedCrossRef Giovannetti ER, Wolff JL, Xue QL, Weiss CO, Leff B, Boult C, et al. Difficulty assisting with health care tasks among caregivers of multimorbid older adults. J Gen Intern Med. 2012;27(1):37–44.PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354(4):379–86.PubMedCrossRef Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354(4):379–86.PubMedCrossRef
35.
Zurück zum Zitat Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395–400.PubMedCrossRef Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395–400.PubMedCrossRef
36.
Zurück zum Zitat KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009(113):S1–130. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009(113):S1–130.
37.
Zurück zum Zitat Rahn DD, Abed H, Sung VW, Matteson KA, Rogers RG, Morrill MY, et al. Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials. J Clin Epidemiol. 2011;64(3):293–300.PubMedCentralPubMedCrossRef Rahn DD, Abed H, Sung VW, Matteson KA, Rogers RG, Morrill MY, et al. Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials. J Clin Epidemiol. 2011;64(3):293–300.PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Legare F, Boivin A, van der Weijden T, Pakenham C, Burgers J, Legare J, et al. Patient and public involvement in clinical practice guidelines: a knowledge synthesis of existing programs. Med Dec Making. 2011;31(6):E45–74.CrossRef Legare F, Boivin A, van der Weijden T, Pakenham C, Burgers J, Legare J, et al. Patient and public involvement in clinical practice guidelines: a knowledge synthesis of existing programs. Med Dec Making. 2011;31(6):E45–74.CrossRef
39.
Zurück zum Zitat den Breejen EM, Nelen WL, Knijnenburg JM, Burgers JS, Hermens RP, Kremer JA. Feasibility of a wiki as a participatory tool for patients in clinical guideline development. J Med Internet Res. 2012;14(5):e138.CrossRef den Breejen EM, Nelen WL, Knijnenburg JM, Burgers JS, Hermens RP, Kremer JA. Feasibility of a wiki as a participatory tool for patients in clinical guideline development. J Med Internet Res. 2012;14(5):e138.CrossRef
40.
Zurück zum Zitat MacLean S, Mulla S, Akl EA, Jankowski M, Vandvik PO, Ebrahim S, et al. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e1S–23S.PubMedCentralPubMed MacLean S, Mulla S, Akl EA, Jankowski M, Vandvik PO, Ebrahim S, et al. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e1S–23S.PubMedCentralPubMed
41.
Zurück zum Zitat Butler M, Talley KMC, Burns R, Ripley A, Rothman A, Johnson P, et al. Values of Older Adults Related to Primary and Secondary Prevention. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011. Butler M, Talley KMC, Burns R, Ripley A, Rothman A, Johnson P, et al. Values of Older Adults Related to Primary and Secondary Prevention. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011.
42.
Zurück zum Zitat Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ. 2012;344:e1553.PubMedCrossRef Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ. 2012;344:e1553.PubMedCrossRef
43.
Zurück zum Zitat Vollenweider D, Boyd CM, Puhan MA. High prevalence of potential biases threatens the interpretation of trials in patients with chronic disease. BMC Med. 2011;9:73.PubMedCentralPubMedCrossRef Vollenweider D, Boyd CM, Puhan MA. High prevalence of potential biases threatens the interpretation of trials in patients with chronic disease. BMC Med. 2011;9:73.PubMedCentralPubMedCrossRef
44.
Zurück zum Zitat Boyd CM, Vollenweider D, Puhan MA. Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases. PLoS One. 2012;7(8):e41601.PubMedCentralPubMedCrossRef Boyd CM, Vollenweider D, Puhan MA. Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases. PLoS One. 2012;7(8):e41601.PubMedCentralPubMedCrossRef
45.
Zurück zum Zitat Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence–indirectness. J Clin Epidemiol. 2011;64(12):1303–10.PubMedCrossRef Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence–indirectness. J Clin Epidemiol. 2011;64(12):1303–10.PubMedCrossRef
46.
Zurück zum Zitat Guyatt GH, Helfand M, Kunz R. Comparing the USPSTF and GRADE approaches to recommendations. Ann Intern Med. 2009;151(5):363. author reply 63-4.PubMedCrossRef Guyatt GH, Helfand M, Kunz R. Comparing the USPSTF and GRADE approaches to recommendations. Ann Intern Med. 2009;151(5):363. author reply 63-4.PubMedCrossRef
47.
Zurück zum Zitat Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. Comparing the USPSTF and GRADE Approaches to Recommendations. Ann Intern Med. 2009;151(5):363–64.CrossRef Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. Comparing the USPSTF and GRADE Approaches to Recommendations. Ann Intern Med. 2009;151(5):363–64.CrossRef
48.
Zurück zum Zitat Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007;298(10):1209–12.PubMedCrossRef Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007;298(10):1209–12.PubMedCrossRef
49.
Zurück zum Zitat Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011;26(7):783–90.PubMedCentralPubMedCrossRef Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011;26(7):783–90.PubMedCentralPubMedCrossRef
50.
Zurück zum Zitat Leipzig RM, Whitlock EP, Wolff TA, Barton MB, Michael YL, Harris R, et al. Reconsidering the approach to prevention recommendations for older adults. Ann Intern Med. 2010;153(12):809–14.PubMedCrossRef Leipzig RM, Whitlock EP, Wolff TA, Barton MB, Michael YL, Harris R, et al. Reconsidering the approach to prevention recommendations for older adults. Ann Intern Med. 2010;153(12):809–14.PubMedCrossRef
51.
Zurück zum Zitat Trikalinos TA, Kulasingam S, Lawrence WF. Chapter 10: deciding whether to complement a systematic review of medical tests with decision modeling. J Gen Intern Med. 2012;27(Suppl 1):S76–82.PubMedCrossRef Trikalinos TA, Kulasingam S, Lawrence WF. Chapter 10: deciding whether to complement a systematic review of medical tests with decision modeling. J Gen Intern Med. 2012;27(Suppl 1):S76–82.PubMedCrossRef
52.
Zurück zum Zitat You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e531S–75S.PubMedCentralPubMed You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e531S–75S.PubMedCentralPubMed
53.
54.
Zurück zum Zitat Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G, Nicolucci A, et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med. 2009;151(12):854–60.PubMedCrossRef Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G, Nicolucci A, et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med. 2009;151(12):854–60.PubMedCrossRef
55.
Zurück zum Zitat Justice AC, McGinnis KA, Skanderson M, Chang CC, Gibert CL, Goetz MB, et al. Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med. 2010;11(2):143–51.PubMedCentralPubMedCrossRef Justice AC, McGinnis KA, Skanderson M, Chang CC, Gibert CL, Goetz MB, et al. Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med. 2010;11(2):143–51.PubMedCentralPubMedCrossRef
56.
Zurück zum Zitat Minne L, Ludikhuize J, de Rooij SE, Abu-Hanna A. Characterizing predictive models of mortality for older adults and their validation for use in clinical practice. J Am Geriatr Soc. 2011;59(6):1110–5.PubMedCrossRef Minne L, Ludikhuize J, de Rooij SE, Abu-Hanna A. Characterizing predictive models of mortality for older adults and their validation for use in clinical practice. J Am Geriatr Soc. 2011;59(6):1110–5.PubMedCrossRef
57.
59.
Zurück zum Zitat Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:85.PubMedCentralPubMedCrossRef Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:85.PubMedCentralPubMedCrossRef
60.
Zurück zum Zitat Tinetti ME, McAvay GJ, Chang SS, Newman AB, Fitzpatrick AL, Fried TR, et al. Contribution of multiple chronic conditions to universal health outcomes. J Am Geriatr Soc. 2011;59(9):1686–91. Tinetti ME, McAvay GJ, Chang SS, Newman AB, Fitzpatrick AL, Fried TR, et al. Contribution of multiple chronic conditions to universal health outcomes. J Am Geriatr Soc. 2011;59(9):1686–91.
Metadaten
Titel
A Framework for Crafting Clinical Practice Guidelines that are Relevant to the Care and Management of People with Multimorbidity
verfasst von
Katrin Uhlig, MS, MD
Bruce Leff, MD
David Kent, MD, Cm, MSc
Sydney Dy, MD, MSc
Klara Brunnhuber, MD
Jako S. Burgers, MD, PhD
Sheldon Greenfield, MD
Gordon Guyatt, MD, MSc
Kevin High, MD
Rosanne Leipzig, MD, PhD
Cynthia Mulrow, MD, MSc
Kenneth Schmader, MD
Holger Schunemann, MD, MSc, PhD
Louise C. Walter, MD
James Woodcock, PhD, MSc, BA(Hons)
Cynthia M. Boyd, MD, MPH
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 4/2014
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2659-y

Weitere Artikel der Ausgabe 4/2014

Journal of General Internal Medicine 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.